uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
UNIQURE (NASDAQ: QURE) Delayed: 45.68 +1.18 (2.65%)
Previous Close $44.50    52 Week High $22.79 
Open $43.38    52 Week Low $6.63 
Day High $46.25    P/E N/A 
Day Low $43.05    EPS $0.00 
Volume 1,396,861